[Addison's disease followed-up for 11 years. Comatose episodes, development of polyendocrine diseases. Pathogenetic and therapeutic considerations].
D058186:Acute Kidney Injury / Q000150:complications / Q000209:etiology*; D000224:Addison Disease / Q000150:complications* / Q000188:drug therapy; D003128:Coma / Q000188:drug therapy / Q000209:etiology*; D003345:Corticosterone / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000188:drug therapy / Q000209:etiology*; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008875:Middle Aged; D013963:Thyroid Hormones / Q000627:therapeutic use
D004967:Estrogens; D013963:Thyroid Hormones; D005947:Glucose; D003345:Corticosterone; D006854:Hydrocortisone
Maladie d'Addison suivie pendant 11 années. Episodes comateux, constitution progressive d'une poly-endocrinose. Considérations pathogéniques et thérapeutiques.